Disclosures: Jay Luther: Nothing to Disclose, Eric Barash: Nothing to Disclose, Benjamin Grobman: Nothing to Disclose, Peter Rentzepis: Nothing to Disclose, Russell Goodman: Nothing to Disclose, Esperance Schaefer: Nothing to Disclose, Michael Butler: Nothing to Disclose, Prasanna Challa: Nothing to Disclose, Wei Zhang: Nothing to Disclose 1586 FEASIBILITY OF RADIOMICS IN PREDICTION OF OVERALL MORTALITY IN SEVERE ALCOHOLIC HEPATITIS: A PILOT STUDY Hyunseok Kim 1 Ally Hatcher 1 Vikrant Rachakonda 2 Linda Azab 1 Touseef Qureshi 1 Lixia Wang 1 Ji Hye Min 3 Polly Kirsch 1 Yee Hui Yeo 1 Walid Ayoub 4 Alexander Kuo 4 Hirsh Trivedi 1 Aarshi Vipani 1 Yun Wang 1 Stephen Pandol 1 Ju Dong Yang 4 Shelly Lu 1 Debiao Li 1 , 1 Cedars Sinai Medical Center, 2 University of Maryland, Baltimore, 3 Samsung Medical Center, 4 Cedars-Sinai Medical Center Background: Radiomics, which involves extracting large amounts of quantitative features from medical images using advanced algorithms, has shown promise in enhancing diagnostic and prognostic accuracy in various medical fields
In dermatology research, double-blind clinical trials have demonstrated that GHK-Cu cream applied for 12 weeks produced a 70% improvement in skin laxity, 35% increase in procollagen synthesis, and measurable increases in dermal thickness (Finkley et al., 2005)
Authored by : Provided by : University of Hawai'i at Manoa
That represents 60% to 85% savings
